
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 10, 2023, titled "Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its Solid Oral Formulation Facility (F-4) at Jarod".
Filed with NSE ·

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 10, 2023, titled "Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its Solid Oral Formulation Facility (F-4) at Jarod".
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals